Medtronic plc (LON:0Y6X)
London · Delayed Price · Currency is GBP · Price in USD 96.98
-0.86 (-0.88%)
At close: Feb 20, 2026
Medtronic Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 23, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
Revenue | 35,484 | 33,537 | 32,364 | 31,227 | 31,686 | 30,117 |
Revenue Growth (YoY) | 6.88% | 3.62% | 3.64% | -1.45% | 5.21% | 4.16% |
Cost of Revenue | 12,359 | 11,606 | 11,091 | 10,622 | 10,028 | 10,355 |
Gross Profit | 23,125 | 21,931 | 21,273 | 20,605 | 21,658 | 19,762 |
Selling, General & Admin | 11,235 | 10,748 | 10,339 | 10,237 | 10,047 | 9,956 |
Research & Development | 2,886 | 2,732 | 2,735 | 2,696 | 2,746 | 2,493 |
Amortization of Goodwill & Intangibles | 1,928 | 1,807 | 1,693 | 1,698 | 1,733 | 1,783 |
Other Operating Expenses | 426 | 241 | 115 | 405 | 285 | 40 |
Operating Expenses | 16,475 | 15,528 | 14,882 | 15,036 | 14,811 | 14,272 |
Operating Income | 6,650 | 6,403 | 6,391 | 5,569 | 6,847 | 5,490 |
Interest Expense | -713 | -729 | -719 | -583 | -553 | -925 |
Interest & Investment Income | 511 | 511 | 597 | 386 | 186 | - |
Currency Exchange Gain (Loss) | 306 | 306 | 176 | 672 | 198 | -230 |
Other Non Operating Income (Expenses) | -1 | 11 | 15 | 124 | 36 | 340 |
EBT Excluding Unusual Items | 6,753 | 6,502 | 6,460 | 6,168 | 6,714 | 4,675 |
Merger & Restructuring Charges | -410 | -303 | -828 | -645 | -1,110 | -617 |
Impairment of Goodwill | - | - | - | -61 | - | - |
Gain (Loss) on Sale of Investments | -358 | -213 | -308 | - | 8 | - |
Gain (Loss) on Sale of Assets | - | - | - | -75 | - | - |
Legal Settlements | -302 | -317 | -149 | 30 | -95 | -118 |
Other Unusual Items | -121 | -42 | -338 | -53 | - | - |
Pretax Income | 5,562 | 5,627 | 4,837 | 5,364 | 5,517 | 3,895 |
Income Tax Expense | 923 | 936 | 1,133 | 1,580 | 456 | 265 |
Earnings From Continuing Operations | 4,639 | 4,691 | 3,704 | 3,784 | 5,061 | 3,630 |
Minority Interest in Earnings | -26 | -29 | -28 | -26 | -22 | -24 |
Net Income | 4,613 | 4,662 | 3,676 | 3,758 | 5,039 | 3,606 |
Net Income to Common | 4,613 | 4,662 | 3,676 | 3,758 | 5,039 | 3,606 |
Net Income Growth | 8.29% | 26.82% | -2.18% | -25.42% | 39.74% | -24.70% |
Shares Outstanding (Basic) | 1,282 | 1,286 | 1,328 | 1,330 | 1,342 | 1,345 |
Shares Outstanding (Diluted) | 1,288 | 1,290 | 1,330 | 1,333 | 1,351 | 1,354 |
Shares Change (YoY) | -0.82% | -3.03% | -0.19% | -1.38% | -0.19% | 0.21% |
EPS (Basic) | 3.60 | 3.63 | 2.77 | 2.83 | 3.75 | 2.68 |
EPS (Diluted) | 3.58 | 3.61 | 2.76 | 2.82 | 3.73 | 2.66 |
EPS Growth | 9.15% | 30.80% | -2.13% | -24.40% | 40.23% | -24.86% |
Free Cash Flow | 5,410 | 5,185 | 5,200 | 4,580 | 5,978 | 4,885 |
Free Cash Flow Per Share | 4.20 | 4.02 | 3.91 | 3.44 | 4.42 | 3.61 |
Dividend Per Share | 2.830 | 2.800 | 2.760 | 2.720 | 2.520 | 2.320 |
Dividend Growth | 1.43% | 1.45% | 1.47% | 7.94% | 8.62% | 7.41% |
Gross Margin | 65.17% | 65.39% | 65.73% | 65.98% | 68.35% | 65.62% |
Operating Margin | 18.74% | 19.09% | 19.75% | 17.83% | 21.61% | 18.23% |
Profit Margin | 13.00% | 13.90% | 11.36% | 12.03% | 15.90% | 11.97% |
Free Cash Flow Margin | 15.25% | 15.46% | 16.07% | 14.67% | 18.87% | 16.22% |
EBITDA | 9,581 | 9,113 | 9,038 | 8,266 | 9,554 | 8,192 |
EBITDA Margin | 27.00% | 27.17% | 27.93% | 26.47% | 30.15% | 27.20% |
D&A For EBITDA | 2,931 | 2,710 | 2,647 | 2,697 | 2,707 | 2,702 |
EBIT | 6,650 | 6,403 | 6,391 | 5,569 | 6,847 | 5,490 |
EBIT Margin | 18.74% | 19.09% | 19.75% | 17.83% | 21.61% | 18.23% |
Effective Tax Rate | 16.59% | 16.63% | 23.42% | 29.46% | 8.27% | 6.80% |
Updated Jan 23, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.